Cargando…
Targeting the Id1-Kif11 Axis in Triple-Negative Breast Cancer Using Combination Therapy
The basic helix-loop-helix (bHLH) transcription factors inhibitor of differentiation 1 (Id1) and inhibitor of differentiation 3 (Id3) (referred to as Id) have an important role in maintaining the cancer stem cell (CSC) phenotype in the triple-negative breast cancer (TNBC) subtype. In this study, we...
Autores principales: | Thankamony, Archana P., Murali, Reshma, Karthikeyan, Nitheesh, Varghese, Binitha Anu, Teo, Wee S., McFarland, Andrea, Roden, Daniel L., Holliday, Holly, Konrad, Christina Valbirk, Cazet, Aurelie, Dodson, Eoin, Yang, Jessica, Baker, Laura A., George, Jason T., Levine, Herbert, Jolly, Mohit Kumar, Swarbrick, Alexander, Nair, Radhika |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565337/ https://www.ncbi.nlm.nih.gov/pubmed/32911668 http://dx.doi.org/10.3390/biom10091295 |
Ejemplares similares
-
Phenotypic heterogeneity drives differential disease outcome in a mouse model of triple negative breast cancer
por: Thankamony, Archana P., et al.
Publicado: (2023) -
Id Proteins Promote a Cancer Stem Cell Phenotype in Mouse Models of Triple Negative Breast Cancer via Negative Regulation of Robo1
por: Teo, Wee S., et al.
Publicado: (2020) -
Cancer Stem Cell Plasticity – A Deadly Deal
por: Thankamony, Archana P., et al.
Publicado: (2020) -
New insights into the role of ID proteins in breast cancer metastasis: a MET affair
por: Teo, Wee Siang, et al.
Publicado: (2014) -
Proteogenomic analysis of Inhibitor of Differentiation 4 (ID4) in basal-like breast cancer
por: Baker, Laura A., et al.
Publicado: (2020)